SuperworthLite Strategy market cap LITS
Share price times shares outstanding: what the whole company sells for, since 2025.
- Today, Oct 23, 2026
- $35.3M
- Highest close in our data
- $91.3M
- Oct 2025
Lite Strategy is worth $35.3M at the close on Oct 23, 2026, at $1.16 a share.
That is down 49% over the last year.
Its highest close in our data was $91.3M in Oct 2025.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $35.3M | $25.2M | $56.6M | −29% |
| 2025 | $49.7M | $17.1M | $91.3M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Lite Strategy's size, closest first, today.
| Company | Market cap |
|---|---|
| LITSLite Strategy | $35.3M |
| ATNMActinium Pharmaceuticals | $47.8M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| NATRNatures Sunshine Products | $213.8M |
| Peer median | $69M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Lite Strategy
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.